Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s373, 2024. DOI: 10.25251/skin.8.supp.373. Disponível em: https://skin.dermsquared.com/skin/article/view/2607. Acesso em: 19 apr. 2026.